Ignite Creation Date:
2025-12-24 @ 9:47 PM
Ignite Modification Date:
2026-01-01 @ 6:06 PM
Study NCT ID:
NCT01040832
Status:
COMPLETED
Last Update Posted:
2017-01-30
First Post:
2009-12-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Sponsor:
EMD Serono
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EMR 200068-006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None